Methotrexate IV infusion 200mg, manufactured by Pfizer (YJ code: 4222400A1036, 200mg 8mL 1 bottle), is a chemotherapy drug and immunosuppressant. It is used to treat certain types of cancer, such as acute lymphocytic leukemia, non-Hodgkin lymphoma, breast cancer, and osteosarcoma, as well as severe psoriasis and rheumatoid arthritis.
Methotrexate IV infusion 200mg
Need more detailed information?
Contact TASAKI PHARMA for product sourcing, availability, or related support (English support available).